Key statistics
As of last trade, Enovis Corp (C520:FRA) traded at 45.60, 29.55% above the 52 week low of 35.20 set on Oct 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 45.60 |
---|---|
High | 45.60 |
Low | 45.60 |
Bid | 45.60 |
Offer | 46.40 |
Previous close | 44.60 |
Average volume | 0.22 |
---|---|
Shares outstanding | 55.88m |
Free float | 55.34m |
P/E (TTM) | -- |
Market cap | 2.61bn USD |
EPS (TTM) | -2.21 USD |
Data delayed at least 15 minutes, as of Nov 26 2024 07:05 GMT.
More ▼
- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces Third Quarter 2024 Results
- Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
- Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
- Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
- Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
- Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
- Enovis Announces Second Quarter 2024 Results
- Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
- Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
More ▼